Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Monday, December 7, 2009, 8:20PM ET - U.S. Markets Closed.
Dow
0.01%
Nasdaq
0.22%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
K V PHARMA CL B (KV-B)
At
3:33PM ET
:
3.91
0.19
(4.63%)
MORE ON KV-B
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Headlines
Get
Headlines
for:
Change Display [
hide $$
edit
]
Wed, Dec 2, 2009
KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet
PR Newswire
(Wed, Dec 2)
Fri, Nov 13, 2009
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
PR Newswire
(Fri, Nov 13)
Mon, Sep 21, 2009
KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)
PR Newswire
(Mon, Sep 21)
Tue, Sep 15, 2009
KV Pharmaceutical Receives Stockholder Action by Written Consent
PR Newswire
(Tue, Sep 15)
Wed, Sep 9, 2009
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
PR Newswire
(Wed, Sep 9)
Wed, Mar 4, 2009
Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B
GlobeNewswire
(Wed, Mar 4)
Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B
GlobeNewswire
(Wed, Mar 4)
Thu, Jan 22, 2009
Brower Piven Announces Expanded Class Period and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in KV Pharmaceutical Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit B
Marketwire
(Thu, Jan 22)
Wed, Jan 14, 2009
Milberg LLP Announces Its Investigation on Behalf of Certain Investors of KV Pharmaceutical -- KV.A
Marketwire
(Wed, Jan 14)
Older Headlines
-
Download Recent Headlines
View headlines from:
Wed, Jan 14, 2009
Wed, Jan 7, 2009
Wed, Dec 31, 2008
Wed, Dec 24, 2008
Wed, Dec 17, 2008
Wed, Dec 10, 2008
Wed, Dec 3, 2008
Wed, Nov 26, 2008
Wed, Nov 19, 2008
Wed, Nov 12, 2008
Add KV-B News to My Yahoo!:
Add to Portfolio
Set Alert
Email to a Friend
Get
Headlines
for Another Symbol:
Symbol Lookup
Stocks In Play
Story Stocks
Full Coverage